flash column chromatography (petrol–ethyl acetate, 6 : 4) to give
acetate, 3 : 2) indicated the formation of a single product (Rf 0.3)
and complete consumption of the starting material (Rf 0.5).
The solution was then concentrated in vacuo and purified by
flash column chromatography (petrol–ethyl acetate, 3 : 2) to
give trifluoromethylbenzamide 8d (38 mg, 61%) as a colourless
hexamide 8b (94 mg, 33%) as a colourless oil; nmax (thin film) 3742
-1
=
(br, NH), 1641 (br, NC O) cm ; dH (400 MHz, CDCl3) (a : b,
10 : 1), 0.88–0.90 (3.3H, m, CH3), 1.22–1.35 (4.4H, m, 2 ¥ CH2),
2.08–2.13 (2.2H, m, CH2), 1.54–1.60 (2.2H, m, CH2), 2.02 (3H, s,
COCH3-a), 2.04 (0.3H, s, COCH3-b), 2.05 (0.3H, s, COCH3-b),
2.06 (3H, s, COCH3-a), 2.09 (0.3H, s, COCH3-b), 2.10 (3H, s,
COCH3-a), 2.14 (0.3H, s, COCH3-b), 2.17 (3H, s, COCH3-a),
3.73–3.76 (0.1H, m, H-5b), 3.99 (0.1H, d at, J 4.1 Hz, J4,5 10.7 Hz,
H-5a), 4.08–4.20 (2.2H, m, H-6a, H-6a, H-6b, H-6b), 4.21–4.29
(1.1H, m, H-4a, H-4b), 5.03–5.07 (0.1H, m, H-2b), 5.11 (1H, dd,
J1,2 3.5 Hz, J2,3 10.1 Hz, H-2a), 5.13–5.15 (0.1H, m, H-3b), 5.33
(1H, at, J 10.4 Hz, H-3a), 5.50–5.52 (1.1H, m, NH-a, NH-b),
5.68 (0.1H, d, J1,2 7.9 Hz, H-1b), 6.36 (1H, d, J 3.5 Hz, H-1a); dC
(100.6 MHz, CD3OH) a (major) anomer only: 13.9 (CH3), 20.5,
20.7, 20.8, 20.9 (COCH3), 22.3, 25.2, 31.3, 36.6 (CH2), 49.9 (C-4),
62.6 (C-6), 69.3 (C-2), 69.4 (C-3), 71.7 (C-5), 89.3 (C-1) 168.7,
169.6, 170.9, 171.5, 173.2 (COCH3, CONH); m/z (ES+) 913.3
=
foam; nmax (thin film) 3520 (br, NH), 1652 (br, NC O), 1360 (s,
C-F) cm-1; dH (400 MHz, CDCl3) (a : b, 5 : 1), 2.01 (0.6H, s,
COCH3-b), 2.02 (3H, s, COCH3-a), 2.04 (3H, s, COCH3-a),
2.07 (0.6H, s, COCH3-b), 2.08 (0.6H, s, COCH3-b), 2.10 (3H, s,
COCH3-a), 2.13 (0.6H, s, COCH3-b), 2.18 (3H, s, COCH3-a),
3.87–3.91 (0.2H, m, H-5b), 4.10–4.14 (1H, ddd, J5-4 10.7 Hz, J5–6
7.6 Hz, J
2.8 Hz, H-5a), 4.24–4.26 (2.4H, m, H-6a, H-6¢a,
5–6¢
H-6b, H-6b), 4.39–4.49 (1.2H, m, H-4a, H-4b), 5.20 (1H, dd,
J2–3 10.4 Hz, J2-1 3.8 Hz, H-2a), 5.23–5.26 (0.2H, m, H-3b), 5.30
(0.2H, at, J 10.4 Hz, H-2b), 5.48 (1H, at, J 10.4 Hz, H-3a), 5.74
(0.2H, d, J1,2 8.3 Hz, H-1b), 6.41 (1H, d, J1,2 3.5 Hz, H-1a),
6.44 (1H, d, J 9.1 Hz, NH-a), 6.63 (0.2H, d, J 9.1 Hz, NH-b),
7.70–7.72 (2.4H, m, 2 ¥ ArH-a, 2 ¥ ArH-b), 7.83–7.85 (2.4H,
m, 2 ¥ ArH-a, 2 ¥ ArH-b); dC (100.6 MHz, CDCl3) a (major)
anomer only: 20.5, 20.7, 20.8, 20.9 (COCH3), 50.9 (C-4), 62.9
(C-6), 69.2 (C-2), 69.5 (C-3), 71.7 (C-5), 89.3 (C-1) 125.8, 127.5
(ArCH), 133.5, 136.5 (ArC), 166.1, 168.7, 169.6, 171.0, 172.0
+
(2M + Na+, 80), 908 (2M+ NH4 , 100), 855 (2M + H+, 50%), 468
(M + Na+, 30), 463 (M + NH4 , 40), 446 (M + H+, 50%) HRMS
+
(ES+) Calcd. for C20H31NO10 (MNa+) 468.1840. Found 468.1825.
1,2,3,6-Tetra-O-acetyl-4-benzamido-4-deoxy-D-glucopyranoside
(8c). Azide 4a (35 mg, 0.09 mmol) was dissolved in dry DCM
(2 mL) under an atmosphere of argon. PPh3 (25 mg, 0.09 mmol)
and benzoyl chloride (22 mL, 0.18 mmol) were then added, and
the reaction mixture was allowed to stir at reflux. After 5 days,
t.l.c. (petrol–ethyl acetate, 1 : 1) indicated the formation of a
single product (Rf 0.25) and complete consumption of the starting
material (Rf 0.6). The solution was diluted with DCM (5 mL),
washed with sodium bicarbonate (5 mL of a saturated aqueous
solution), brine, dried (MgSO4), filtered and concentrated in vacuo.
The residue was purified by flash column chromatography (petrol–
(COCH3, CONH); m/z (ES+) (M + NH4 , 100%); HRMS (ES+)
+
Calcd. for C22H24F3NO10 (MNa+) 542.1245. Found 542.1244.
4-Isobutylamido-4-deoxy-D-glucopyranose
(9a). Acetylated
amide 8a (70 mg, 0.17 mmol) was dissolved in methanol (5 mL).
Freshly prepared NaOMe (0.01 mL of a 1 M solution) was
then added portion-wise. The reaction was monitored by t.l.c.
(DCM–methanol, 4 : 1) which upon completion indicated the
formation of a single product (Rf 0.7). Amberlight IR-120 (H+)
was then added until the solution was at pH 7; the solution was
filtered and concentrated in vacuo to afford de-protected amide
ethyl acetate, 1 : 1) to give benzamide 8c (25 mg, 59%) as a white
9a (47 mg, 100%) as a white solid; mp 169–170 ◦C; nmax (thin
-1
-1
=
=
=
solid; nmax (thin film) 3630 (br, NH), 1644 (br, NC O) cm ; dH
film) 3320 (br, OH), 1745 (br, C O), 1658 (br, NC O), cm ; dH
(400 MHz, methanol-d4) (a : b, 1 : 1), 1.16 (12H, m, (CH3)2CH-b,
(CH3)2CH-a), 2.52 (2H, m, (CH3)2CH-a, (CH3)2CH-b), 3.16–
3.24 (1H, m, H-2b), 3.44 (1H, dd, J1,2 3.5 Hz, J2,3 9.1 Hz, H-2a),
3.48–3.52 (2H, m, H-4a, H-4b), 3.54–3.60 (5H, m, H-5b, H-6a,
H-6¢a, H-6b, H-6¢b, ), 3.66–3.72 (2H, m, H-3a, H-3b), 3.79–3.83
(3H, m, H-5a, NH-a, NH-b), 4.48 (1H, d, J1,2 7.6 Hz, H-1b)
5.18 (1H, d, J 3.5 Hz, H-1a); dC (100.6 MHz, methanol-d4) 19.7,
19.9 (CH3), 36.4, 37.2 ((CH3)2CH), 53.0, 53.1, 63.0, 63.1, 71.9,
72.4, 74.6, 75.2, 77.1, 77.4 (C-2, C-3, C-4, C-5, C-6), 94.1, 98.3
(C-1), 181.2, 181.3 (CONH); m/z (ES+) 521 (2M + Na+, 50), 272
(M + Na+, 35), 250.1 (M + H+, 10%); HRMS (ES+) Calcd. for
C10H19NO6 (MNa+) 272.1105. Found 272.1101.
(400 MHz, CDCl3) (a : b, 9 : 1), 2.0 (0.4H, s, COCH3-b), 2.01
(3H, s, COCH3-a), 2.04 (3H, s, COCH3-a), 2.06 (0.4H, s, COCH3-
b), 2.07 (0.4H, s, COCH3-b), 2.09 (3H, s, COCH3-a), 2.13 (0.4H, s,
COCH3-b), 2.18 (3H, s, COCH3-a), 4.11 (1H, d at, J 3.1 Hz, J4,5
10.1 Hz, H-5a), 4.20–4.27 (0.4H, m, H-5b), 4.25 (2.3H, m, H-6a,
H-6¢a, H-6b, H-6¢b), 4.46–4.48 (1.1H, m, H-4a, H-4b), 5.05–5.11
(0.1H, m, H-2b), 5.08 (1H, dd, J1,2 3.6 Hz, J2,3 10.3 Hz, H-2a),
5.33 (0.1H, at, J 10.3 Hz, H-3b), 5.48 (1H, at, J 10.3 Hz, H-3a),
5.74 (0.1H, d, J1,2 8.1 Hz, H-1b), 6.29 (1H, d, J 9.2 Hz, NH-a),
6.34 (0.1H, d, J 9.4 Hz, NH-b), 6.41 (1H, d, J 3.6 Hz, H-1a),
7.41–7.46 (2.3H, m, ArH), 7.49–7.54 (1.1H, m, ArH-a, ArH-b),
7.70–7.72 (2.3H, m, 2 ¥ ArH-a, 2 ¥ ArH-b); dC (100.6 MHz,
CDCl3) a (major) anomer only: 20.5, 20.7, 20.8, 20.9 (COCH3),
50.8 (C-4), 62.9 (C-6), 69.3 (C-3), 69.4 (C-2), 71.8 (C-5), 89.3 (C-
1), 126.9, 128.8, 130.8, 132.1, 133.3 (ArCH), 167.3, 168.8, 169.6,
170.1, 171.9 (COCH3, CONH); m/z (ES+) 925 (2M + Na+, 30),
474 (M + Na+, 60%); HRMS (ES+) Calcd. for C21H25NO10 (MNa+)
474.1371. Found 474.1368.
4-Deoxy-4-hexamido-D-glucopyranose (9b). Protected amide
8b (69 mg, 0.15 mmol) was dissolved in methanol (5 mL).
Freshly prepared NaOMe (0.016 mL of a 1 M solution) was then
added portion-wise. The reaction was monitored by t.l.c. (DCM–
methanol, 4 : 1) which upon completion indicated the formation
of a single product (Rf 0.7). Amberlight IR-120 (H+) was then
added until the solution was at pH 7; the solution was filtered
and concentrated in vacuo to afford de-protected amide 9b (43 mg,
1,2,3,6-Tetra-O-acetyl-4-(4-trifluoromethyl)-benzamido-4-deoxy-
D-glucopyranoside (8d). Azide 4a (45 mg, 0.12 mmol) was
dissolved in dry DCM (5 mL) under an atmosphere of argon.
PBu3 (36 mL, 0.14 mmol) and 4-trifluoromethyl benzoyl chloride
(22 mL, 0.14 mmol) were then added, and the reaction mixture
was allowed to stir at reflux. After 48 h, t.l.c. (petrol–ethyl
100%) as a white solid, mp 136–138 ◦C; nmax (thin film) 3443 (br,
-1
=
OH), 1643 (s, NC O) cm ; dH (400 MHz, methanol-d4) (a : b,
1 : 1), 0.93–0.96 (3.3H, m, CH3-a, CH3-b), 1.34–1.40 (4.4H, m, 2 ¥
CH2-a, 2 ¥ CH2-b), 1.62–1.68 (2.2H, m, CH2-a, CH2-b), 2.24–2.28
This journal is
The Royal Society of Chemistry 2009
Org. Biomol. Chem., 2009, 7, 1097–1105 | 1103
©